SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North AmericaEU edition

Top Headlines

Attention given to preventing adulteration on the rise, but has that curbed the problem?

Is the dietary supplement industry getting a handle on the adulteration issue?  The baseline data does not exist to be able to say one way or another. But sources agree that in the one thing you can measure—the attention the issue is getting—the situation is improving.

Federal GMO labeling bill hailed as 'true compromise,' but critics say it's woefully inadequate

Attempts to reach a federal GMO labeling solution have failed miserably to date. However, a bipartisan deal requiring mandatory GMO labeling (via smartlabels, symbols or as yet undetermined wording) thrashed out in the Senate on Thursday looks like it could prove the exception to the rule.

‘A lot more consumers have digestive issues than they wish to admit’: NutraClick CEO

A combination of more prevalent digestive issues and effects consumers can feel are boosting the US probiotics sector, says the CEO of NutraClick.

Careful market research underlies hangover product's launch

The developers of a new hangover supplement believe careful pre launch market analysis will help them succeed where others have failed.

Industry reaction: What #Brexit means for UK & EU nutrition sectors

For the first time the European Union has lost a member after the British people yesterday voted to leave the bloc which began life as the European Economic Community in 1951.

News in brief

Omega-3 may reduce heart patients’ hospital stay, study finds

Cardiac surgery patients given omega-3 polyunsaturated fatty acids (PUFAs) beforehand found their hospital stay reduced by up to 2.4 days, an analysis has suggested. 

Archive article of the week

Holding up RCTs as 'gold standard' of research is a false hope and conceals statistical pitfalls, experts say

Randomized, placebo-controlled trials are a straitjacket for nutritional science, making FTC’s hardening stance an increasing burden on industry, experts said at the recent CRN conference. The approach poses ethical quandaries and may even have statistical traps built in, they said.

COMMUNITY INSIGHTS

By Kyowa Hakko

Content Provided by Kyowa Hakko

Pantesin® pantethine: Comprehensively aiding cardiovascular health for 40 years

Heart disease is a rare case of a big problem with a clear solution: Lower LDL. In Pantesin, manufacturers have an ingredient with a 40-year history of doing just that.

Key Industry Events